The activity related to the Company’s incentive equity awards for the three months ended March 31, 2020 consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RSUs |
|
PSUs |
|
Number of RSUs |
|
Weighted Average Grant Price |
|
Number of PSUs |
|
Weighted Average Grant Price |
Balance as of December 31, 2019 |
0.8 |
|
|
$ |
55.75 |
|
|
0.1 |
|
|
$ |
52.44 |
|
Granted (a)
|
0.5 |
|
|
53.40 |
|
|
0.1 |
|
|
53.40 |
|
Vested |
(0.1 |
) |
|
53.14 |
|
|
— |
|
|
— |
|
Canceled |
(0.1 |
) |
|
56.02 |
|
|
— |
|
|
— |
|
Balance as of March 31, 2020 |
1.1 |
|
(b) |
$ |
55.02 |
|
|
0.2 |
|
(c) |
$ |
52.94 |
|
______________________
|
|
(a) |
Represents awards granted by the Company in February 2020. |
|
|
(b) |
RSUs outstanding as of March 31, 2020 are expected to vest over time and have an aggregate unrecognized compensation expense of $53 million, which is expected to be recognized over a weighted average period of 3.2 years.
|
|
|
(c) |
PSUs outstanding as of March 31, 2020 are expected to vest over time and have an aggregate unrecognized compensation expense of $10 million, which may be recognized over a weighted average period of 2.4 years.
|
The activity related to stock options granted by the Company for the three months ended March 31, 2020 consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Options |
|
Weighted Average Exercise Price |
|
Weighted Average Remaining Contractual Life (Years) |
|
Aggregate Intrinsic Value (in millions) |
Outstanding as of December 31, 2019 |
0.9 |
|
|
$ |
56.96 |
|
|
|
|
|
Granted |
0.6 |
|
|
53.40 |
|
|
|
|
|
Exercised |
— |
|
|
— |
|
|
|
|
|
Canceled |
— |
|
|
— |
|
|
|
|
|
Expired |
— |
|
|
— |
|
|
|
|
|
Outstanding as of March 31, 2020 |
1.5 |
|
|
$ |
55.51 |
|
|
6.3 |
|
$ |
— |
|
Unvested as of March 31, 2020 |
1.2 |
|
(a) |
$ |
55.13 |
|
|
6.2 |
|
$ |
— |
|
Exercisable as of March 31, 2020 |
0.3 |
|
|
$ |
57.15 |
|
|
6.4 |
|
$ |
— |
|
______________________
(a)
Unvested options as of March 31, 2020 are expected to vest over time and have an aggregate unrecognized compensation expense of $11 million, which is expected to be recognized over a weighted average period of 3.2 years.
|